RaySearch Laboratories

RaySearch to present latest innovations in RayStation, RayCare and RayIntelligence at ISOP and NPC (NAPT)

Retrieved on: 
Thursday, April 4, 2024
Proton, NAPT, Conference, Proton therapy, Research, NPC, RBE, RaySearch Laboratories, Linear energy transfer, Future, National Association, LET, Medical imaging

STOCKHOLM, April 4, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) will present the latest software innovations at IBA's International Symposium on Proton Therapy (ISOP) in Boston, Massachusetts, April 5, and at the National Proton Conference (NPC) run by the National Association on Proton Therapy (NAPT) in Boston, April 6-9.

Key Points: 
  • STOCKHOLM, April 4, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) will present the latest software innovations at IBA's International Symposium on Proton Therapy (ISOP) in Boston, Massachusetts, April 5, and at the National Proton Conference (NPC) run by the National Association on Proton Therapy (NAPT) in Boston, April 6-9.
  • Visit us at RaySearch's table at ISOP and booth at NPC.
  • The focus during both ISOP and NPC will be on support for proton arcs and robust optimization based on linear energy transfer (LET) and adaptive therapy.
  • Marc Mlyn, President of RaySearch Americas, and David McPhail, VP of Sales for RaySearch Americas, will be present at the meetings and look forward to meeting existing and future clinical partners.

RaySearch Laboratories: Year-end report 2023

Retrieved on: 
Friday, February 23, 2024
Mass, Royal Marsden Hospital, Medical college, RaySearch Laboratories, Paul Scherrer Institute, Interim, Artemis, CBCT, Policy

RaySearch secured an order from Israel-based P-Cure and expanded collaboration focusing on advanced proton therapy solutions.

Key Points: 
  • RaySearch secured an order from Israel-based P-Cure and expanded collaboration focusing on advanced proton therapy solutions.
  • The Royal Marsden in the UK will be the first center in the world to implement online adaptive radiation therapy utilizing ARTemis from RaySearch.
  • Telephone: +46 (0)8 510 530 00, [email protected]
    Telephone: +46 (0)8 510 530 00, [email protected]
    The information contained in this interim report is such that RaySearch Laboratories AB (publ) is obliged to disclose under the EU Market Abuse Regulation and the Swedish Securities Market Act.
  • CEO Johan Löf and Interim CFO Annika Blondeau Henriksson will present RaySearch's year-end report for January-December 2023 at a webcast to be held in English on Friday, February 23, 2024 at 10:00-10:30 a.m. CET.

The Royal Marsden set to be the first center in the world to implement online adaptive radiation therapy utilizing ARTemis from RaySearch

Retrieved on: 
Thursday, February 8, 2024
RaySearch Laboratories, Research, Patient, Radiation, Institute of Cancer Research, Physics, Disease, Royal Marsden Hospital, Anatomy, Hospital

Thanks to funding from The Royal Marsden Cancer Charity, the center recently acquired two additional Radixact treatment delivery machines from Accuray with the intention to utilize these machines for OART.

Key Points: 
  • Thanks to funding from The Royal Marsden Cancer Charity, the center recently acquired two additional Radixact treatment delivery machines from Accuray with the intention to utilize these machines for OART.
  • ARTemis is a collaborative effort between RaySearch and Accuray, aiming to provide an online adaptive solution for clinicians using the RayStation treatment planning system with the Radixact Treatment Delivery System.
  • The Royal Marsden in Sutton plans to implement the full ARTemis package, which has also been funded by The Royal Marsden Cancer Charity.
  • Johan Löf, founder and CEO, RaySearch, says: "I am a strong believer of the clinical benefits of adaptive radiation therapy.

RayStation in more than 1,000 radiotherapy centers worldwide

Retrieved on: 
Wednesday, January 31, 2024
Education, RaySearch Laboratories, Research, Carbon, Proton, Radiation, Noetics, WPE, Pharmaceutical industry

STOCKHOLM, Jan. 31, 2024 /PRNewswire/ -- RaySearch Laboratories AB (pub) is proud to announce that the number of radiotherapy centers that have chosen RayStation®* for treatment planning now exceeds 1,000.

Key Points: 
  • STOCKHOLM, Jan. 31, 2024 /PRNewswire/ -- RaySearch Laboratories AB (pub) is proud to announce that the number of radiotherapy centers that have chosen RayStation®* for treatment planning now exceeds 1,000.
  • The first version of RayStation was launched in 2009 and the system is now available in cancer centers in 43 countries worldwide.
  • The United States has the largest number of RayStation centers with more than 285 customers, followed by Japan, with around 220 centers, and China, where around 90 centers have bought RayStation.
  • The first ever customer for RayStation was Westdeutsches Protonentherapiezentrum Essen (WPE) in Germany, who bought RayStation in 2009.

The Froedtert & Medical College of Wisconsin health network selects RayStation

Retrieved on: 
Thursday, January 18, 2024
Patient, Radiation therapy, Medical college, Health, Proton therapy, Froedtert Hospital, RaySearch Laboratories, Cancer, MCW, LET, Accuray

STOCKHOLM, Jan. 18, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces that the Froedtert & Medical College of Wisconsin health network, USA, has placed an order for the treatment planning system RayStation®*.

Key Points: 
  • STOCKHOLM, Jan. 18, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces that the Froedtert & Medical College of Wisconsin health network, USA, has placed an order for the treatment planning system RayStation®*.
  • The Froedtert & MCW health network has purchased RayStation for photon treatments on its Elekta linear accellerators and the Accuray Radixact® treatment delivery system, as well as hyperscanning proton licenses for the health network's upcoming Mevion S250i proton therapy system.
  • The Froedtert & MCW health network offers a nationally and internationally recognized premier cancer program with six cancer centers anchored by the only academic medical center in eastern Wisconsin.
  • The Clinical Cancer Center at the health network's Froedtert Hospital campus anticipates being the first center in Wisconsin to offer proton therapy.

RaySearch releases RayStation 2024A

Retrieved on: 
Friday, December 22, 2023
Cancer, Workflow, Weight loss, Blood, Patient, RaySearch Laboratories

STOCKHOLM, Dec. 22, 2023 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2024A, the latest version of the company's comprehensive treatment planning system.

Key Points: 
  • STOCKHOLM, Dec. 22, 2023 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2024A, the latest version of the company's comprehensive treatment planning system.
  • RayStation 2024A also brings the possibility to define clinical planning goals for both the combined plan and the constituent sub-plans, and evaluate correspondingly.
  • The workflow for enhancing daily images to allow for accurate dose computation is further improved with RayStation 2024A.
  • With RayStation 2024A we also continue with improvements within fast adaptive re-planning, which will be an important focus area during the coming years."

Vejle Hospital becomes first center in the world to use RayStation for an online adaptive treatment with augmented CBCT

Retrieved on: 
Monday, November 20, 2023
Online, Gy, Acquisition, Teaching hospital, RaySearch Laboratories, CBCT, Workflow, Cancer, VMAT, Health, Pharmaceutical industry, Medical imaging

The improved workflow is enabled by the adaptive replanning capabilities of RayStation®* and significantly saves time for the patient.

Key Points: 
  • The improved workflow is enabled by the adaptive replanning capabilities of RayStation®* and significantly saves time for the patient.
  • Thanks to the synthetic CT algorithm and fast adaptive replanning capabilities in RayStation, the CBCT of the first treatment fraction can be used for creating an adapted plan during the treatment session.
  • In the current example, the online adaptation was motivated by differences in positioning at image acquisition and at treatment.
  • RayStation has very advanced tools available for taking online adaptive into clinical routine and the work done by Vejle is showcasing what groundbreakning possibilities our users have to further advance cancer treatments."

RaySearch Laboratories: Interim report January 1 - September 30, 2023

Retrieved on: 
Friday, November 17, 2023
Paul Scherrer Institute, CFO, Mass, Cyberknife, CET, University Medical Center Groningen, RaySearch Laboratories, Lausanne University Hospital, University, Partnership, CHUV, Pharmaceutical industry, Nursing, Flour

RaySearch and MedAustron expand their partnership through a new strategic research agreement.

Key Points: 
  • RaySearch and MedAustron expand their partnership through a new strategic research agreement.
  • RaySearch's business partner IBA has placed an order for RayStation and RayCare for installation at CRO National Cancer Institute (C.R.O.)
  • RaySearch has received an order from Israel-based P-Cure and is deepening its collaboration focusing on advanced proton therapy solutions.
  • CEO Johan Löf and interim CFO Annika Blondeau Henriksson will present RaySearch's interim report for January - September 2023 at a webcast to be held in English on Friday, November 17, 2023 at 10:00-10:30 a.m. CET.

Oregon Health & Science University (OHSU) to utilize RayStation technology for radiation therapy planning

Retrieved on: 
Tuesday, October 31, 2023
Cancer, Medicine, Patient, RaySearch Laboratories, Health, OHSU, Research, Medical device, Accuray, Physics, Q3

The center intends to implement adaptive therapy to acquire daily patient images and perform treatment adaptations such that the patient's treatment is optimized.

Key Points: 
  • The center intends to implement adaptive therapy to acquire daily patient images and perform treatment adaptations such that the patient's treatment is optimized.
  • OHSU and RaySearch consider this approach to precision medicine to be the future of radiation therapy.
  • Dr. John Bayouth, Vice Chair, Director of Physics and Chief Medical Physicist at OHSU says: "OHSU is building the organization's technological platforms for advanced radiation therapy.
  • Johan Löf, founder and CEO, RaySearch, says: "I am greatly encouraged that OHSU will integrate RayStation with Radixact, marking another step forward in our commitment to advancing radiation technology.

Invitation to presentation of RaySearch's interim report for the third quarter of 2023

Retrieved on: 
Monday, October 30, 2023
CET, CFO, RaySearch Laboratories, Webcast, Cryptocurrency, Internet service provider

STOCKHOLM, Oct. 30, 2023 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the third quarter of 2023 on November 17, 2023, at 10.00 am CET.

Key Points: 
  • STOCKHOLM, Oct. 30, 2023 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the third quarter of 2023 on November 17, 2023, at 10.00 am CET.
  • The report will be published on November 17, 2023, at 07.45 am and will be available together with presentation slides on raysearchlabs.com .
  • Johan Löf, founder and CEO, and Annika Blondeau Henriksson, interim CFO, will present the company's development in a webcast.
  • After the presentation (held in English) there is the opportunity to ask questions.